• Cobenfy: A New Antipsychotic

  • Oct 7 2024
  • Length: 12 mins
  • Podcast

Cobenfy: A New Antipsychotic

Listen for free

View show details

  • Summary

  • KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three EMERGENT trials that led to its FDA approval.

    CME: Take the CME Post-Test for this Episode

    Published On: 10/07/2024

    Duration: 12 minutes, 28 seconds

    Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Cobenfy: A New Antipsychotic

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available